Rational Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $32.1K | Buy |
+72
| New | +$32.1K | ﹤0.01% | 148 |
|
|
2023
Q4 | – | Sell |
-641
| Closed | -$223K | – | 275 |
|
|
2023
Q3 | $223K | Buy |
641
+259
| +68% | +$90.1K | 0.02% | 112 |
|
|
2023
Q2 | $134K | Buy |
+382
| New | +$134K | 0.01% | 135 |
|
|
2020
Q4 | – | Sell |
-23
| Closed | -$6K | – | 591 |
|
|
2020
Q3 | $6K | Buy |
23
+4
| +21% | +$1.04K | ﹤0.01% | 357 |
|
|
2020
Q2 | $6K | Buy |
+19
| New | +$6K | ﹤0.01% | 416 |
|
|
2020
Q1 | – | Sell |
-927
| Closed | -$203K | – | 512 |
|
|
2019
Q4 | $203K | Buy |
927
+833
| +886% | +$182K | 0.1% | 187 |
|
|
2019
Q3 | $16K | Sell |
94
-4,249
| -98% | -$723K | 0.01% | 472 |
|
|
2019
Q2 | $797K | Buy |
4,343
+1,517
| +54% | +$278K | 0.28% | 122 |
|
|
2019
Q1 | $520K | Buy |
+2,826
| New | +$520K | 0.14% | 144 |
|
|
2018
Q4 | – | Sell |
-104
| Closed | -$20K | – | 573 |
|
|
2018
Q3 | $20K | Buy |
104
+100
| +2,500% | +$19.2K | ﹤0.01% | 360 |
|
|
2018
Q2 | $1K | Sell |
4
-82
| -95% | -$20.5K | ﹤0.01% | 494 |
|
|
2018
Q1 | $14K | Buy |
+86
| New | +$14K | 0.01% | 353 |
|
|
2015
Q3 | $6K | Hold |
54
| – | – | ﹤0.01% | 388 |
|
|
2015
Q2 | $7K | Hold |
54
| – | – | ﹤0.01% | 393 |
|
|
2015
Q1 | $6K | Sell |
54
-36
| -40% | -$4K | ﹤0.01% | 410 |
|
|
2014
Q4 | $11K | Buy |
+90
| New | +$11K | ﹤0.01% | 417 |
|
|
2013
Q4 | $351K | Sell |
4,727
-569
| -11% | -$42.3K | 0.03% | 395 |
|
|
2013
Q3 | $402K | Sell |
5,296
-52
| -1% | -$3.95K | 0.03% | 408 |
|
|
2013
Q2 | $428K | Buy |
+5,348
| New | +$428K | 0.04% | 396 |
|